Connectathon 11 Snapshot
This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
This is a value set defined at http://healthcaresoa.org 
.
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/hspc-OrdinalLabCodes |
| Name: | HSPC Ordinal Labs |
| Definition: | Ordinal LOINC codes used in HSPC |
| OID: | 2.16.840.1.113883.4.642.2.0 (for OID based terminology systems) |
| Copyright: | This content LOINC® is copyright © 1995 Regenstrief Institute, Inc. and the LOINC Committee, and available at no cost under the license at http://loinc.org/terms-of-use |
| Source Resource | XML / JSON |
This value set is not currently used
This value set includes codes from the following code systems:
| Code | Display | |
| 1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells | |
| 1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells | |
| 10374-7 | Helmet cells [Presence] in Blood by Light microscopy | |
| 10378-8 | Polychromasia [Presence] in Blood by Light microscopy | |
| 10380-4 | Stomatocytes [Presence] in Blood by Light microscopy | |
| 10381-2 | Target cells [Presence] in Blood by Light microscopy | |
| 10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay | |
| 11060-1 | Reducing substances [Presence] in Stool | |
| 11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe and target amplification method|Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe and target amplification method | |
| 11281-3 | Auer rods [Presence] in Blood by Light microscopy | |
| 11483-5 | Varicella zoster virus DNA [Presence] in Unspecified specimen by Probe and target amplification method|Varicella zoster virus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 12239-0 | Oligosaccharides [Presence] in Urine | |
| 12454-5 | Urate crystals amorphous [Presence] in Urine sediment by Light microscopy | |
| 12598-9 | Fat.neutral [Presence] in Stool | |
| 12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot (IB) | |
| 13248-0 | Hepatitis D virus Ab [Presence] in Serum | |
| 13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid|Xanthochromia of Cerebral spinal fluid Qualitative | |
| 13533-5 | Acid hemolysis [Presence] of Blood | |
| 13578-0 | Promazine [Presence] in Serum or Plasma | |
| 13655-6 | Leukocytes [Presence] in Stool by Light microscopy | |
| 13931-1 | Striated muscle Ab [Presence] in Serum | |
| 13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum by Immunoassay | |
| 13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum by Immunoassay|Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay | |
| 13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay | |
| 13952-7 | Hepatitis B virus core Ab [Presence] in Serum by Immunoassay|Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay | |
| 13953-5 | Hepatitis B virus e Ab [Presence] in Serum by Immunoassay | |
| 14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence | |
| 14273-7 | Reticulin IgA Ab [Presence] in Serum | |
| 14564-9 | Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen | |
| 14565-6 | Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen | |
| 15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) | |
| 15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma | |
| 16128-1 | Hepatitis C virus Ab [Presence] in Serum | |
| 16369-1 | Amphetamines [Presence] in Urine by Confirmatory method | |
| 16933-4 | Hepatitis B virus core Ab [Presence] in Serum | |
| 16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot (IB) | |
| 16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot (IB) | |
| 17257-7 | Mesothelial cells [Presence] in Body fluid by Light microscopy | |
| 17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence | |
| 17783-2 | Hemosiderin [Presence] in Urine by Light microscopy | |
| 17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum | |
| 18282-4 | Cannabinoids [Presence] in Urine by Screen method | |
| 18311-1 | Pelger Huet cells [Presence] in Blood by Light microscopy | |
| 18312-9 | Platelet satellitism [Presence] in Blood by Light microscopy | |
| 18390-5 | Opiates [Presence] in Urine by Confirmatory method | |
| 18481-2 | Streptococcus pyogenes Ag [Presence] in Throat | |
| 19162-7 | Varicella zoster virus IgG Ab [Presence] in Serum | |
| 19252-6 | Megakaryocytes/100 leukocytes in Blood | |
| 1928-1 | Immunoglobulin light chains [Presence] in Urine | |
| 19429-0 | Propoxyphene [Presence] in Urine by Screen method | |
| 19554-5 | Methamphetamine [Presence] in Urine by Screen method | |
| 1977-8 | Bilirubin [Presence] in Urine|Bilirubin.total [Presence] in Urine | |
| 20404-0 | Fibronectin.fetal [Presence] in Vaginal fluid | |
| 20411-5 | Barbiturates [Mass/volume] in Urine by Confirmatory method | |
| 20421-4 | Barbiturates [Presence] in Serum or Plasma by Screen method | |
| 20507-0 | Reagin Ab [Presence] in Serum by RPR | |
| 2106-3 | Choriogonadotropin (pregnancy test) [Presence] in Urine | |
| 2118-8 | Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma | |
| 21233-2 | Cryptosporidium sp Ag [Presence] in Stool | |
| 21348-8 | HTLV 1+2 IgG Ab [Presence] in Serum by Immunoassay | |
| 21518-6 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum | |
| 21523-6 | Smith extractable nuclear IgG Ab [Presence] in Serum | |
| 21560-8 | Thermoactinomyces candidus Ab [Presence] in Serum | |
| 21561-6 | Thermoactinomyces sacchari Ab [Presence] in Serum | |
| 21695-2 | HFE gene p.C282Y [Presence] in Blood or Tissue by Molecular genetics method | |
| 21696-0 | HFE gene p.H63D [Presence] in Blood or Tissue by Molecular genetics method | |
| 21747-1 | HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | |
| 21753-9 | TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method | |
| 22239-8 | Cytomegalovirus Ab [Presence] in Serum | |
| 22295-0 | Epstein Barr virus early IgG Ab [Presence] in Serum | |
| 22310-7 | Helicobacter pylori Ab [Presence] in Serum | |
| 22362-8 | HTLV 1+2 Ab [Presence] in Serum | |
| 22415-4 | Mumps virus IgG Ab [Presence] in Serum | |
| 22566-4 | Streptococcus pyogenes enzyme Ab [Presence] in Serum | |
| 22572-2 | Saccharomonospora viridis Ab [Presence] in Serum | |
| 2334-1 | Hemoglobin.gastrointestinal [Presence] in Gastric fluid | |
| 2335-8 | Hemoglobin.gastrointestinal [Presence] in Stool | |
| 2349-9 | Glucose [Presence] in Urine | |
| 2350-7 | Glucose [Mass/volume] in Urine | |
| 23785-9 | Trypanosoma cruzi Ab [Presence] in Serum | |
| 23820-4 | Aspergillus flavus Ab [Presence] in Serum by Immune diffusion (ID) | |
| 23826-1 | Bordetella pertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method|Bordetella pertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 23867-5 | Hantavirus sin nombre IgG Ab [Titer] in Serum | |
| 23868-3 | Hantavirus sin nombre IgM Ab [Titer] in Serum | |
| 23929-3 | Ribonucleoprotein extractable nuclear IgG Ab [Presence] in Serum | |
| 23980-6 | Borrelia burgdorferi IgG Ab [Presence] in Body fluid by Immunoblot (IB) | |
| 23982-2 | Borrelia burgdorferi IgM Ab [Presence] in Body fluid by Immunoblot (IB) | |
| 24015-0 | Influenza virus A+B Ag [Presence] in Unspecified specimen | |
| 24027-5 | Streptococcus pneumoniae Ag [Presence] in Urine | |
| 24111-7 | Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and target amplification method|Neisseria gonorrhoeae DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 24113-3 | Hepatitis B virus core IgM Ab [Presence] in Serum by Immunoassay|Hepatitis B virus core IgM Ab [Presence] in Serum or Plasma by Immunoassay | |
| 24114-1 | Epstein Barr virus capsid IgG Ab [Presence] in Serum by Immunoassay | |
| 24115-8 | Epstein Barr virus capsid IgM Ab [Presence] in Serum by Immunoassay | |
| 24119-0 | Cytomegalovirus IgM Ab [Presence] in Serum by Immunoassay | |
| 24312-1 | Treponema pallidum Ab [Presence] in Serum by Agglutination | |
| 2432-3 | Homogentisate [Presence] in Urine | |
| 2474-5 | Indicans [Presence] in Urine | |
| 2514-8 | Ketones [Presence] in Urine by Test strip | |
| 25514-1 | Rubella virus IgG Ab [Presence] in Serum | |
| 2606-2 | Melanin [Presence] in Urine | |
| 26620-5 | Hantavirus IgG Ab [Presence] in Serum | |
| 26960-5 | Trypsin [Presence] in Stool | |
| 27270-8 | 4-Hydroxyphenylacetate [Presence] in Urine | |
| 27420-9 | Phosphatidylglycerol [Units/volume] in Amniotic fluid | |
| 2761-5 | Phenylketones [Presence] in Blood | |
| 28005-7 | MTHFR gene p.C677T [Presence] in Blood or Tissue by Molecular genetics method|MTHFR gene c.677C>T [Presence] in Blood or Tissue by Molecular genetics method | |
| 28060-2 | MTHFR gene p.A1298C [Presence] in Blood or Tissue by Molecular genetics method|MTHFR gene c.1298A>C [Presence] in Blood or Tissue by Molecular genetics method | |
| 28067-7 | Hemoglobin F [Presence] in Amniotic fluid | |
| 2887-8 | Protein [Presence] in Urine | |
| 29257-3 | Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by Probe and target amplification method|Mycoplasma pneumoniae DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29495-9 | Herpes virus 6 DNA [Presence] in Unspecified specimen by Probe and target amplification method|Herpes virus 6 DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29497-5 | Platelet associated IgG Ab [Presence] in Blood by Flow cytometry (FC) | |
| 29498-3 | Platelet associated IgM Ab [Presence] in Blood by Flow cytometry (FC) | |
| 29591-5 | Enterovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method|Enterovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29610-3 | Hepatitis B virus DNA [Presence] in Serum or Plasma by Probe and target amplification method|Hepatitis B virus DNA [Presence] in Serum or Plasma by Probe and target amplification method | |
| 29672-3 | Bordetella pertussis IgA Ab [Presence] in Serum | |
| 29673-1 | Bordetella pertussis IgM Ab [Presence] in Serum | |
| 29674-9 | Bordetella pertussis IgG Ab [Presence] in Serum | |
| 29723-4 | Bordetella parapertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method|Bordetella parapertussis DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29771-3 | Hemoglobin.gastrointestinal [Presence] in Stool by Immunologic method | |
| 29778-8 | West Nile virus IgM Ab [Presence] in Unspecified specimen by Immunoassay | |
| 29891-9 | Helicobacter pylori [Presence] in Stomach by urea breath test | |
| 29899-2 | Gamma globulin [Presence] in 24 hour Urine | |
| 29901-6 | HTLV 1+2 Ab [Presence] in Serum by Immunoassay | |
| 29908-1 | Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Parainfluenza virus 1 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29909-9 | Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Parainfluenza virus 2 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29910-7 | Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Parainfluenza virus 3 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 29945-3 | Alpha 1 globulin [Presence] in 24 hour Urine by Electrophoresis | |
| 29947-9 | Alpha 2 globulin [Presence] in 24 hour Urine by Electrophoresis | |
| 29950-3 | Nuclear IgG Ab [Presence] in Serum by Immunoassay | |
| 29951-1 | Beta globulin [Presence] in 24 hour Urine | |
| 29990-9 | Spermatozoa [Presence] in Semen by Light microscopy --post vasectomy | |
| 29994-1 | Basement membrane IgG Ab [Presence] in Serum by Immunofluorescence | |
| 29995-8 | Basement membrane IgA Ab [Presence] in Serum by Immunofluorescence | |
| 30036-8 | Aspergillus fumigatus 2 Ab [Presence] in Serum by Immune diffusion (ID) | |
| 30167-1 | Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe and signal amplification method|Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+68 DNA [Presence] in Cervix by Probe and signal amplification method | |
| 30219-0 | Coxsackievirus A9 Ab [Presence] in Serum | |
| 30246-3 | Cytomegalovirus DNA [Presence] in Serum or Plasma by Probe and target amplification method|Cytomegalovirus DNA [Presence] in Serum or Plasma by Probe and target amplification method | |
| 30361-0 | HIV 2 Ab [Presence] in Serum by Immunoassay | |
| 30557-3 | Smooth muscle IgG Ab [Presence] in Serum | |
| 30577-1 | 2-methyl,3-hydroxybutyrate (C5-OH) [Presence] in Urine | |
| 31153-0 | Coccidioides sp Ab [Presence] in Unspecified specimen by Immune diffusion (ID) | |
| 31201-7 | HIV 1+2 Ab [Presence] in Serum by Immunoassay|HIV 1+2 Ab [Presence] in Serum or Plasma by Immunoassay | |
| 31539-0 | Neuronal nuclear type 2 Ab [Presence] in Serum | |
| 31545-7 | Nuclear IgG Ab [Presence] in Serum | |
| 31588-7 | Ribonucleoprotein extractable nuclear IgG Ab [Units/volume] in Serum | |
| 31625-7 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum | |
| 31626-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum | |
| 31627-3 | Smith extractable nuclear Ab [Presence] in Serum | |
| 31788-3 | Cryptococcus sp Ag [Presence] in Cerebral spinal fluid | |
| 31843-6 | Helicobacter pylori Ag [Presence] in Stool | |
| 31859-2 | Influenza virus A Ag [Presence] in Unspecified specimen | |
| 31864-2 | Influenza virus B Ag [Presence] in Unspecified specimen | |
| 31969-9 | Streptococcus pneumoniae Ag [Presence] in Unspecified specimen | |
| 32131-5 | Hantavirus IgM Ab [Presence] in Serum | |
| 32356-8 | Yeast [Presence] in Urine sediment by Light microscopy | |
| 32358-4 | Protein fractions.oligoclonal bands [Presence] in Cerebral spinal fluid | |
| 3241-7 | Coagulation factor XIII coagulum dissolution at 24H [Presence] in Platelet poor plasma by Coagulation assay|Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assay | |
| 32637-1 | Urease [Presence] in Tissue | |
| 32765-0 | Yeast [Presence] in Unspecified specimen by Wet preparation | |
| 32789-0 | Viscosity of Semen Qualitative | |
| 33031-6 | Sodium urate crystals [#/area] in Urine sediment by Microscopy low power field | |
| 33032-4 | Spermatozoa Progressive [Presence] in Semen | |
| 33291-6 | Herpes simplex virus 1 IgG Ab [Presence] in Serum by Immunoblot (IB) | |
| 33422-7 | Amphiphysin Ab [Presence] in Serum | |
| 3349-8 | Amphetamines [Presence] in Urine | |
| 33615-6 | Neuronal nuclear type 1 Ab [Presence] in Serum | |
| 3376-1 | Barbiturates [Presence] in Serum, Plasma or Blood | |
| 3377-9 | Barbiturates [Presence] in Urine | |
| 33861-6 | Starch granules [Presence] in Urine sediment by Light microscopy | |
| 3390-2 | Benzodiazepines [Presence] in Urine | |
| 33923-4 | Hemosiderin [Presence] in Unspecified specimen | |
| 33930-9 | Lupus anticoagulant neutralization hexagonal phase phospholipid [Presence] in Platelet poor plasma|aPTT W excess hexagonal phospholipid (StaClot LA confirm) | |
| 3414-0 | Buprenorphine [Presence] in Urine | |
| 34469-7 | Leukocytes [Presence] in Bile fluid by Light microscopy | |
| 34470-5 | Giardia lamblia Ag [Presence] in Bile fluid | |
| 34471-3 | Calcium bilirubinate crystals [Presence] in Bile fluid by Light microscopy | |
| 34472-1 | Cholesterol crystals [Presence] in Bile fluid by Light microscopy | |
| 34473-9 | Neutrophils.vacuolated+Segmented [Presence] in Blood | |
| 34487-9 | Influenza virus A RNA [Presence] in Unspecified specimen by Probe and target amplification method|Influenza virus A RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 34701-3 | Ab [Presence] in Serum|Platelet Ab.heparin induced [Presence] in Serum|Heparin induced platelet Ab [Presence] in Serum | |
| 34706-2 | CFTR gene p.3199 del6 [Presence] in Blood or Tissue by Molecular genetics method|CFTR gene c.3199del6 [Presence] in Blood or Tissue by Molecular genetics method | |
| 34713-8 | Clostridium difficile toxin A+B [Presence] in Stool | |
| 34729-4 | CFTR gene p.R117H+5T variant [Presence] in Blood or Tissue by Molecular genetics method | |
| 34892-0 | West Nile virus RNA [Presence] in Unspecified specimen by Probe and target amplification method|West Nile virus RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 35270-8 | Candida sp Ab [Presence] in Serum by Immune diffusion (ID) | |
| 35271-6 | Candida sp Ag [Presence] in Serum by Latex agglutination | |
| 35272-4 | Centromere IgG Ab [Presence] in Serum | |
| 35277-3 | Myocardium IgG Ab [Presence] in Serum | |
| 35284-9 | Histone IgG Ab [Presence] in Serum | |
| 35471-2 | HLA Ab [Presence] | |
| 35492-8 | Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] by Probe and target amplification method|Methicillin resistant Staphylococcus aureus (MRSA) DNA [Presence] by Probe and target amplification method | |
| 35503-2 | Arterial patency Wrist artery --pre arterial puncture | |
| 35729-3 | Chlamydia sp DNA [Presence] in Unspecified specimen by Probe and target amplification method|Chlamydia sp DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 3773-9 | Methadone [Presence] in Urine | |
| 38380-2 | HFE gene p.S65C [Presence] in Blood or Tissue by Molecular genetics method | |
| 3879-4 | Opiates [Presence] in Urine | |
| 38917-1 | Human metapneumovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method|Human metapneumovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 3936-2 | Phencyclidine [Presence] in Urine | |
| 39528-5 | Adenovirus DNA [Presence] in Unspecified specimen by Probe and target amplification method|Adenovirus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 4027-9 | Secobarbital [Presence] in Serum or Plasma | |
| 40473-1 | Thermoactinomyces vulgaris 1 Ab [Presence] in Serum | |
| 40703-1 | Lactoferrin [Presence] in Stool by Immunoassay | |
| 40729-6 | Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay | |
| 4073-3 | Tricyclic antidepressants [Presence] in Serum or Plasma | |
| 4093-1 | Verapamil [Presence] in Serum or Plasma | |
| 40982-1 | Influenza virus B RNA [Presence] in Unspecified specimen by Probe and target amplification method|Influenza virus B RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 40988-8 | Respiratory syncytial virus RNA [Presence] in Unspecified specimen by Probe and target amplification method|Respiratory syncytial virus RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 40991-2 | Rhinovirus+Enterovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method|Rhinovirus+Enterovirus RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 41005-0 | Human coronavirus NL63 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Human coronavirus NL63 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 41010-0 | Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Parainfluenza virus 4 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 41400-3 | Yersinia sp IgA Ab [Presence] in Serum by Immunoblot (IB) | |
| 41401-1 | Yersinia sp IgG Ab [Presence] in Serum by Immunoblot (IB) | |
| 42241-0 | Cocaine+Benzoylecgonine [Presence] in Urine by Screen method | |
| 42481-2 | Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe and signal amplification method|Human papilloma virus 6+11+42+43+44 DNA [Presence] in Cervix by Probe and signal amplification method | |
| 42714-6 | t(9,22)(ABL1,BCR) p210 Translocation [Presence] in Blood or Tissue by Molecular genetics method|t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | |
| 42938-1 | CFTR gene allele 1 [Presence] in Blood or Tissue by Molecular genetics method | |
| 42939-9 | CFTR gene allele 2 [Presence] in Blood or Tissue by Molecular genetics method | |
| 43249-2 | X ray dye crystals [Presence] in Urine sediment by Light microscopy | |
| 43399-5 | JAK2 gene p.V617F [Presence] in Blood or Tissue by Molecular genetics method | |
| 43597-4 | Inner Ear 68kD Ab [Presence] in Serum or Plasma by Immunoblot (IB) | |
| 44099-0 | Galactomannan Ag [Presence] in Serum or Plasma by Immunoassay | |
| 44332-5 | Jo-1 extractable nuclear IgG Ab [Presence] in Serum | |
| 44754-0 | Hepatitis D virus Ag [Presence] in Serum by Immunoassay | |
| 44877-9 | Insulin dependent diabetes mellitus [Presence] | |
| 44938-9 | Hepatitis D virus IgM Ab [Presence] in Serum by Immunoassay | |
| 45153-4 | HLA Ab in Serum | |
| 4579-9 | Hemoglobin F [Presence] in Blood | |
| 4631-8 | Hemoglobin F [Presence] in Stool by Apt-Downey method | |
| 4639-1 | Unstable Hemoglobin [Presence] in Red Blood Cells | |
| 46740-7 | Hemoglobin disorders newborn screen interpretation | |
| 46771-2 | Classical galactosemia newborn screen interpretation | |
| 47238-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunoassay | |
| 47251-4 | BK virus DNA [Presence] in Unspecified specimen by Probe and target amplification method|BK virus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 49524-2 | Influenza virus A H3 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Influenza virus A H3 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 49541-6 | Fasting status [Presence] - Reported|Fasting status - Reported | |
| 49795-8 | t(9,22)(ABL1,BCR) p190 Translocation [Presence] in Blood or Tissue by Molecular genetics method|t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript [Presence] in Blood or Tissue by Molecular genetics method | |
| 5000-5 | Cytomegalovirus DNA [Presence] in Unspecified specimen by Probe and target amplification method|Cytomegalovirus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 5005-4 | Epstein Barr virus DNA [Presence] in Unspecified specimen by Probe and target amplification method|Epstein Barr virus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 5010-4 | Hepatitis C virus RNA [Presence] in Blood by Probe and target amplification method|Hepatitis C virus RNA [Presence] in Blood by Probe and target amplification method | |
| 5014-6 | Herpes simplex virus DNA [Presence] in Unspecified specimen by Probe and target amplification method|Herpes simplex virus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 5018-7 | HIV 1 RNA [Presence] in Unspecified specimen by Probe and target amplification method|HIV 1 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 5020-3 | Legionella sp rRNA [Presence] in Unspecified specimen by DNA probe | |
| 5028-6 | Neisseria gonorrhoeae rRNA [Presence] in Unspecified specimen by DNA probe | |
| 50322-7 | MLH-1 Ag [Presence] in Tissue by Immune stain | |
| 50323-5 | MSH-2 Ag [Presence] in Tissue by Immune stain | |
| 50324-3 | MSH-6 Ag [Presence] in Tissue by Immune stain | |
| 50328-4 | PMS-2 Ag [Presence] in Tissue by Immune stain | |
| 50385-4 | Alpha-1-Microglobulin.placental [Presence] in Vaginal fluid | |
| 5052-6 | Aspergillus sp Ab [Presence] in Serum by Immune diffusion (ID) | |
| 5058-3 | Blastomyces dermatitidis Ab [Presence] in Serum by Immune diffusion (ID) | |
| 51006-5 | Direct antiglobulin test.unspecified reagent [Presence] on Red Blood Cells | |
| 5117-7 | Cryoglobulin [Presence] in Serum | |
| 5156-5 | Epstein Barr virus nuclear IgG Ab [Presence] in Serum by Immunoassay | |
| 5195-3 | Hepatitis B virus surface Ag [Presence] in Serum | |
| 5196-1 | Hepatitis B virus surface Ag [Presence] in Serum by Immunoassay|Hepatitis B virus surface Ag [Presence] in Serum or Plasma by Immunoassay | |
| 5199-5 | Hepatitis C virus Ab [Presence] in Serum by Immunoblot (IB) | |
| 5213-4 | Heterophile Ab [Presence] in Serum by Latex agglutination | |
| 5218-3 | Histoplasma capsulatum Ab [Presence] in Serum by Immune diffusion (ID) | |
| 5290-2 | Reagin Ab [Presence] in Cerebral spinal fluid by VDRL | |
| 5292-8 | Reagin Ab [Presence] in Serum by VDRL | |
| 5297-7 | Rheumatoid factor [Presence] in Serum by Latex agglutination | |
| 5358-7 | Smooth muscle Ab [Titer] in Serum by Immunofluorescence | |
| 5393-4 | Treponema pallidum Ab [Presence] in Serum by Immunofluorescence | |
| 54067-4 | Clostridium difficile toxin genes [Presence] in Stool by Probe and target amplification method|Clostridium difficile toxin genes [Presence] in Stool by Probe and target amplification method | |
| 54142-5 | Candida sp DNA [Presence] in Vaginal fluid by Probe and signal amplification method|Candida sp DNA [Presence] in Vaginal fluid by Probe and signal amplification method | |
| 54143-3 | Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe and signal amplification method|Gardnerella vaginalis DNA [Presence] in Vaginal fluid by Probe and signal amplification method | |
| 54144-1 | Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe and signal amplification method|Trichomonas vaginalis DNA [Presence] in Vaginal fluid by Probe and signal amplification method | |
| 54905-5 | Norovirus 1 RNA [Presence] in Stool by Probe and target amplification method|Norovirus 1 RNA [Presence] in Stool by Probe and target amplification method|Norovirus Genogroup I RNA [Presence] in Stool by Probe and target amplification method | |
| 54906-3 | Norovirus 2 RNA [Presence] in Stool by Probe and target amplification method|Norovirus 2 RNA [Presence] in Stool by Probe and target amplification method|Norovirus Genogroup II RNA [Presence] in Stool by Probe and target amplification method | |
| 550-4 | Bordetella pertussis Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 55464-2 | Influenza virus A swine origin RNA [Presence] in Unspecified specimen by Probe and target amplification method|Influenza virus A swine origin RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 55465-9 | Influenza virus A H1 2009 pandemic RNA [Presence] in Unspecified specimen by Probe and target amplification method|Influenza virus A H1 2009 pandemic RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 5766-1 | Ammonium urate crystals [Presence] in Urine sediment by Light microscopy | |
| 5770-3 | Bilirubin [Presence] in Urine by Test strip|Bilirubin.total [Presence] in Urine by Test strip | |
| 5771-1 | Bilirubin crystals [Presence] in Urine sediment by Light microscopy | |
| 5773-7 | Calcium carbonate crystals [Presence] in Urine sediment by Light microscopy | |
| 5774-5 | Calcium oxalate crystals [Presence] in Urine sediment by Light microscopy | |
| 5775-2 | Calcium phosphate crystals [Presence] in Urine sediment by Light microscopy | |
| 5777-8 | Cholesterol crystals [Presence] in Urine sediment by Light microscopy | |
| 5783-6 | Unidentified crystals [Presence] in Urine sediment by Light microscopy | |
| 5784-4 | Cystine crystals [Presence] in Urine sediment by Light microscopy | |
| 57901-1 | Clostridium difficile glutamate dehydrogenase [Presence] in Stool | |
| 5794-3 | Hemoglobin [Presence] in Urine by Test strip | |
| 5795-0 | Hippurate crystals [Presence] in Urine sediment by Light microscopy | |
| 5799-2 | Leukocyte esterase [Presence] in Urine by Test strip | |
| 58012-6 | Natalizumab Ab [Presence] in Serum | |
| 5802-4 | Nitrite [Presence] in Urine by Test strip | |
| 5809-9 | Reducing substances [Presence] in Urine | |
| 5813-1 | Trichomonas vaginalis [Presence] in Urine sediment by Light microscopy | |
| 5814-9 | Triple phosphate crystals [Presence] in Urine sediment by Light microscopy | |
| 5815-6 | Tyrosine crystals [Presence] in Urine sediment by Light microscopy | |
| 5817-2 | Urate crystals [Presence] in Urine sediment by Light microscopy | |
| 58415-1 | BRAF gene p.V600E [Presence] in Tissue by Molecular genetics method | |
| 58416-9 | MLH1 gene methylation [Presence] in Tissue by Molecular genetics method | |
| 5846-1 | Herpes simplex virus 1 Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 5849-5 | Herpes simplex virus 2 Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 5863-6 | Influenza virus A Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 5867-7 | Influenza virus B Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 58751-9 | Treponema pallidum IgG Ab [Presence] in Cerebral spinal fluid by Immunofluorescence | |
| 5876-8 | Respiratory syncytial virus Ag [Presence] in Unspecified specimen by Immunoassay | |
| 5880-0 | Rotavirus Ag [Presence] in Stool by Immunoassay | |
| 588-4 | Legionella pneumophila Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 59262-6 | Leukocyte esterase [Presence] in Cerebral spinal fluid by Test strip | |
| 59420-0 | Human papilloma virus16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe and signal amplification method|Human papilloma virus 16+18+31+33+35+39+45+51+52+56+58+59+66+68 DNA [Presence] in Cervix by Probe and signal amplification method | |
| 59838-3 | Cytomegalovirus Ab [Presence] in Serum or Plasma by Latex agglutination | |
| 59839-1 | Urate crystals [Presence] in Tissue by Light microscopy | |
| 60340-7 | Crystals.amorphous [Presence] in Urine sediment by Light microscopy | |
| 61404-0 | Staphylococcus aureus DNA [Presence] in Unspecified specimen by Probe and target amplification method|Staphylococcus aureus DNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 62423-9 | Human coronavirus HKU1 RNA [Presence] in Unspecified specimen by Probe and target amplification method|Human coronavirus HKU1 RNA [Presence] in Unspecified specimen by Probe and target amplification method | |
| 62862-8 | Microsatellite instability [Presence] in Tissue by Immune stain | |
| 6306-5 | Adenovirus C(40)+B(41) Ag [Presence] in Stool by Immunoassay|Adenovirus 40+41 Ag [Presence] in Stool by Immunoassay | |
| 6320-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoblot (IB) | |
| 6321-4 | Borrelia burgdorferi IgM Ab [Presence] in Serum by Immunoblot (IB) | |
| 63379-2 | DNA double strand IgG Ab [Presence] in Serum | |
| 6355-2 | Chlamydia trachomatis Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 63558-1 | HLA-DQB1*0602 [Presence] | |
| 6362-8 | Clostridium difficile toxin A+B [Presence] in Stool by Cytotoxin tissue culture assay | |
| 6443-6 | Lactoferrin [Presence] in Stool by Latex agglutination | |
| 6447-7 | Legionella pneumophila Ag [Presence] in Urine by Immunoassay | |
| 6733-0 | Pigeon serum Ab [Presence] in Serum by Immune diffusion (ID) | |
| 6808-0 | Aspergillus fumigatus 1 Ab [Presence] in Serum by Immune diffusion (ID) | |
| 6809-8 | Aspergillus fumigatus 6 Ab [Presence] in Serum by Immune diffusion (ID) | |
| 6810-6 | Aureobasidium pullulans Ab [Presence] in Serum by Immune diffusion (ID) | |
| 6818-9 | Saccharopolyspora rectivirgula Ab [Presence] in Serum by Immune diffusion (ID) | |
| 700-5 | Pneumocystis jiroveci Ag [Presence] in Unspecified specimen by Immunofluorescence | |
| 702-1 | Anisocytosis [Presence] in Blood by Light microscopy | |
| 703-9 | Basophilic stippling [Presence] in Blood by Light microscopy | |
| 716-1 | Heinz bodies [Presence] in Blood by Light microscopy | |
| 728-6 | Hypochromia [Presence] in Blood by Light microscopy | |
| 733-6 | Lymphocytes Variant [Presence] in Blood by Light microscopy | |
| 738-5 | Macrocytes [Presence] in Blood by Light microscopy | |
| 741-9 | Microcytes [Presence] in Blood by Light microscopy | |
| 765-8 | Neutrophils.hypersegmented [Presence] in Blood by Light microscopy | |
| 774-0 | Ovalocytes [Presence] in Blood by Light microscopy | |
| 7789-1 | Acanthocytes [Presence] in Blood by Light microscopy | |
| 7790-9 | Burr cells [Presence] in Blood by Light microscopy | |
| 7791-7 | Dacrocytes [Presence] in Blood by Light microscopy | |
| 7792-5 | Dohle body [Presence] in Blood by Light microscopy | |
| 7793-3 | Howell-Jolly bodies [Presence] in Blood by Light microscopy | |
| 7795-8 | Pappenheimer bodies [Presence] in Blood by Light microscopy | |
| 7796-6 | Platelet clump [Presence] in Blood by Light microscopy | |
| 7797-4 | Rouleaux [Presence] in Blood by Light microscopy | |
| 7798-2 | Smudge cells [Presence] in Blood by Light microscopy | |
| 779-9 | Poikilocytosis [Presence] in Blood by Light microscopy | |
| 7918-6 | HIV 1+2 Ab [Presence] in Serum | |
| 800-3 | Schistocytes [Presence] in Blood by Light microscopy | |
| 801-1 | Sickle cells [Presence] in Blood by Light microscopy | |
| 802-9 | Spherocytes [Presence] in Blood by Light microscopy | |
| 803-7 | Toxic granules [Presence] in Blood by Light microscopy | |
| 8041-6 | Treponema pallidum Ab [Presence] in Serum by Hemagglutination | |
| 8061-4 | Nuclear Ab [Presence] in Serum | |
| 8091-1 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum | |
| 8092-9 | SCL-70 extractable nuclear Ab [Presence] in Serum |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
© HL7.org 2011+. FHIR DSTU2 (v1.2.0-7447) generated on Fri, Dec 11, 2015 17:41+1100.
Links: Search |
Version History |
Table of Contents |
Compare to DSTU1 |
|
Propose a change